Id |
Subject |
Object |
Predicate |
Lexical cue |
T244 |
0-25 |
Sentence |
denotes |
Study population Results |
T245 |
26-41 |
Sentence |
denotes |
Patients, n 57 |
T246 |
42-60 |
Sentence |
denotes |
Medications, n (%) |
T247 |
61-93 |
Sentence |
denotes |
Steroids (for COVID-19) 19 (35) |
T248 |
94-114 |
Sentence |
denotes |
Antibiotics 35 (63) |
T249 |
115-136 |
Sentence |
denotes |
Azitromycin 15 (27) |
T250 |
137-160 |
Sentence |
denotes |
>1 antibiotic 16 (29) |
T251 |
161-178 |
Sentence |
denotes |
Antivirals 5 (9) |
T252 |
179-206 |
Sentence |
denotes |
Lopinavir/ritonavir 3 (5) |
T253 |
207-235 |
Sentence |
denotes |
Darunavir/cobicistat 1 (2) |
T254 |
236-254 |
Sentence |
denotes |
Remdesivir 1 (2) |
T255 |
255-277 |
Sentence |
denotes |
Immunomodulator 3 (5) |
T256 |
278-297 |
Sentence |
denotes |
Tocilizumab 1 (2) |
T257 |
298-315 |
Sentence |
denotes |
Rituximab 1 (2) |
T258 |
316-335 |
Sentence |
denotes |
Ruxolitinib 1 (2) |
T259 |
336-363 |
Sentence |
denotes |
Hydroxychloroquine 24 (44) |
T260 |
364-404 |
Sentence |
denotes |
Oxygen therapy (higher intensity), n (%) |
T261 |
405-421 |
Sentence |
denotes |
Overall 30 (54) |
T262 |
422-445 |
Sentence |
denotes |
Nasal cannula 18 (32) |
T263 |
446-479 |
Sentence |
denotes |
Non-invasive ventilation 8 (14) |
T264 |
480-519 |
Sentence |
denotes |
Invasive mechanical ventilation 4 (7) |
T265 |
520-535 |
Sentence |
denotes |
Outcomes, n (%) |
T266 |
536-549 |
Sentence |
denotes |
Death 7 (12) |
T267 |
550-563 |
Sentence |
denotes |
ARDS 11 (19) |
T268 |
564-584 |
Sentence |
denotes |
ICU admission 4 (7) |
T269 |
585-618 |
Sentence |
denotes |
Hospitalisation (no ICU) 37 (65) |
T270 |
619-651 |
Sentence |
denotes |
Need for rehabilitation 7 (17) |
T271 |
652-693 |
Sentence |
denotes |
Duration of hospitalisation, median (IQR) |
T272 |
694-718 |
Sentence |
denotes |
Hospital stay 10 (7–22) |
T273 |
719-740 |
Sentence |
denotes |
ICU stay 16 (10–19) |
T274 |
741-763 |
Sentence |
denotes |
Rehab stay 14 (11–15) |